Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jeremy Saklatvala
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Physiology
Phenomena
Living Beings
Anatomy
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
17
Clark, Andrew
12
Dean, Jonathan
11
Wait, Robin
9
Sarsfield, Simon
7
Brook, Matthew
6
Hermansson, Monika
6
Sully, Gareth
5
Rawlinson, Lesley
4
Finch, A
4
Begum, Shajna
4
Vincent, Tonia
3
Bolton, Mark
3
Cope, Andrew
3
Peirce, Matthew
3
Kracht, Michael
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jeremy Saklatvala (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Clark Andrew R; Dean Jonathan L E; Saklatvala Jeremy
The p38 MAPK pathway mediates both antiinflammatory and proinflammatory processes: Comment on the article by Damjanov and the editorial by Genovese.
Arthritis and rheumatism 2009;60(11):3513-4.
-
2009: Chia Shi-Lu; Sawaji Yasunobu; Burleigh Annika; McLean Celia; Inglis Julia; Saklatvala Jeremy; Vincent Tonia
Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis.
Arthritis and rheumatism 2009;60(7):2019-27.
-
2009: Tudor Corina; Marchese Francesco P; Hitti Edward; Aubareda Anna; Rawlinson Lesley; Gaestel Matthias; Blackshear Perry J; Clark Andrew R; Saklatvala Jeremy; Dean Jonathan L E
The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages.
FEBS letters 2009;583(12):1933-8.
-
2009: Clark Andrew; Dean Jonathan; Tudor Corina; Saklatvala Jeremy
Post-transcriptional gene regulation by MAP kinases via AU-rich elements.
Frontiers in bioscience : a journal and virtual library 2009;14():847-71.
-
2008: Sawaji Yasunobu; Hynes Judith; Vincent Tonia; Saklatvala Jeremy
Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
Arthritis and rheumatism 2008;58(11):3498-509.
-
2008: Vincent Tonia L; Saklatvala Jeremy
Is the response of cartilage to injury relevant to osteoarthritis?
Arthritis and rheumatism 2008;58(5):1207-10.
-
2007: Alexander Susan; Watt Fiona; Sawaji Yasunobu; Hermansson Monika; Saklatvala Jeremy
Activin A is an anticatabolic autocrine cytokine in articular cartilage whose production is controlled by fibroblast growth factor 2 and NF-kappaB.
Arthritis and rheumatism 2007;56(11):3715-25.
-
2007: Brikos Constantinos; Wait Robin; Begum Shajna; O'Neill Luke A J; Saklatvala Jeremy
Mass spectrometric analysis of the endogenous type I interleukin-1 (IL-1) receptor signaling complex formed after IL-1 binding identifies IL-1RAcP, MyD88, and IRAK-4 as the stable components.
Molecular & cellular proteomics : MCP 2007;6(9):1551-9.
-
2007: Vincent T L; McLean C J; Full L E; Peston D; Saklatvala J
FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2007;15(7):752-63.
-
2007: Alford Kate A; Glennie Sarah; Turrell Bryony R; Rawlinson Lesley; Saklatvala Jeremy; Dean Jonathan L E
Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling.
The Journal of biological chemistry 2007;282(9):6232-41.
-
2007: Saklatvala Jeremy
Inflammatory signaling in cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis.
Current drug targets 2007;8(2):305-13.
-
2007: Peirce Matthew J; Saklatvala Jeremy; Cope Andrew P; Wait Robin
Mapping lymphocyte plasma membrane proteins: a proteomic approach.
Methods in molecular medicine 2007;136():361-7.
-
2007: Hermansson Monika; Saklatvala Jeremy; Wait Robin
Two-dimensional electrophoresis of proteins secreted from articular cartilage.
Methods in molecular medicine 2007;136():349-59.
-
2006: Abraham Sonya M; Lawrence Toby; Kleiman Anna; Warden Paul; Medghalchi Mino; Tuckermann Jan; Saklatvala Jeremy; Clark Andrew R
Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1.
The Journal of experimental medicine 2006;203(8):1883-9.
-
2006: Vincent T; Saklatvala J
Basic fibroblast growth factor: an extracellular mechanotransducer in articular cartilage?
Biochemical Society transactions 2006;34(Pt 3):456-7.
-
2006: Brook Matthew; Tchen Carmen R; Santalucia Tomas; McIlrath Joanne; Arthur J Simon C; Saklatvala Jeremy; Clark Andrew R
Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways.
Molecular and cellular biology 2006;26(6):2408-18.
-
2005: Peirce Matthew J; Begum Shajna; Saklatvala Jeremy; Cope Andrew P; Wait Robin
Two-stage affinity purification for inducibly phosphorylated membrane proteins.
Proteomics 2005;5(9):2417-21.
-
2004: Hermansson Monika; Sawaji Yasunobu; Bolton Mark; Alexander Susan; Wallace Andrew; Begum Shajna; Wait Robin; Saklatvala Jeremy
Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin betaA (activin A), a regulatory molecule for chondrocytes.
The Journal of biological chemistry 2004;279(42):43514-21.
-
2004: Dean Jonathan L E; Sully Gareth; Clark Andrew R; Saklatvala Jeremy
The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation.
Cellular signalling 2004;16(10):1113-21.
-
2004: Gruber Johann; Vincent Tonia L; Hermansson Monika; Bolton Mark; Wait Robin; Saklatvala Jeremy
Induction of interleukin-1 in articular cartilage by explantation and cutting.
Arthritis and rheumatism 2004;50(8):2539-46.
-
2004: Saklatvala Jeremy
The p38 MAP kinase pathway as a therapeutic target in inflammatory disease.
Current opinion in pharmacology 2004;4(4):372-7.
-
2004: Tchen Carmen R; Brook Matthew; Saklatvala Jeremy; Clark Andrew R
The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself.
The Journal of biological chemistry 2004;279(31):32393-400.
-
2004: Vincent Tonia L; Hermansson Monika A; Hansen Ulrich N; Amis Andrew A; Saklatvala Jeremy
Basic fibroblast growth factor mediates transduction of mechanical signals when articular cartilage is loaded.
Arthritis and rheumatism 2004;50(2):526-33.
-
2004: Sully Gareth; Dean Jonathan L E; Wait Robin; Rawlinson Lesley; Santalucia Tomas; Saklatvala Jeremy; Clark Andrew R
Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1).
The Biochemical journal 2004;377(Pt 3):629-39.
-
2004: Peirce Matthew J; Wait Robin; Begum Shajna; Saklatvala Jeremy; Cope Andrew P
Expression profiling of lymphocyte plasma membrane proteins.
Molecular & cellular proteomics : MCP 2004;3(1):56-65.
-
2004: Saklatvala Jeremy; Nagase Hideaki
Report on the Molecular Approaches to Osteoarthritis Symposium, Imperial College London, UK, 18-20 April 2004.
Arthritis research & therapy 2004;6(5):203-7.
-
2003: Dean Jonathan L E; Sarsfield Simon J; Tsounakou Elizabeth; Saklatvala Jeremy
p38 Mitogen-activated protein kinase stabilizes mRNAs that contain cyclooxygenase-2 and tumor necrosis factor AU-rich elements by inhibiting deadenylation.
The Journal of biological chemistry 2003;278(41):39470-6.
-
2003: Clark Andrew R; Dean Jonathan L E; Saklatvala Jeremy
Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38.
FEBS letters 2003;546(1):37-44.
-
2003: Saklatvala Jeremy; Dean Jonathan; Clark Andrew
Control of the expression of inflammatory response genes.
Biochemical Society symposium 2003;(70):95-106.
-
2003: Saklatvala Jeremy; Nagase Hideaki; Salvesen Guy
A tribute to Alan J. Barrett.
Biochemical Society symposium 2003;(70):ix-x.
-
2002: Kracht Michael; Saklatvala Jeremy
Transcriptional and post-transcriptional control of gene expression in inflammation.
Cytokine 2002;20(3):91-106.
-
2002: Lasa Marina; Abraham Sonya M; Boucheron Christine; Saklatvala Jeremy; Clark Andrew R
Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38.
Molecular and cellular biology 2002;22(22):7802-11.
-
2002: Dean Jonathan L E; Sully Gareth; Wait Robin; Rawlinson Lesley; Clark Andrew R; Saklatvala Jeremy
Identification of a novel AU-rich-element-binding protein which is related to AUF1.
The Biochemical journal 2002;366(Pt 3):709-19.
-
2002: Vincent Tonia; Hermansson Monika; Bolton Mark; Wait Robin; Saklatvala Jeremy
Basic FGF mediates an immediate response of articular cartilage to mechanical injury.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(12):8259-64.
-
2002: Saklatvala Jeremy
Glucocorticoids: do we know how they work?
Arthritis research 2002;4(3):146-50.
-
2001: Mahtani K R; Brook M; Dean J L; Sully G; Saklatvala J; Clark A R
Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability.
Molecular and cellular biology 2001;21(19):6461-9.
-
2001: Lasa M; Brook M; Saklatvala J; Clark A R
Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38.
Molecular and cellular biology 2001;21(3):771-80.
-
2001: Dean J L; Wait R; Mahtani K R; Sully G; Clark A R; Saklatvala J
The 3' untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR.
Molecular and cellular biology 2001;21(3):721-30.
-
2001: Finch A; Davis W; Carter W G; Saklatvala J
Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinase kinases 4 and 7.
The Biochemical journal 2001;353(Pt 2):275-81.
-
2000: Brook M; Sully G; Clark A R; Saklatvala J
Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade.
FEBS letters 2000;483(1):57-61.
-
2000: Lasa M; Mahtani K R; Finch A; Brewer G; Saklatvala J; Clark A R
Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade.
Molecular and cellular biology 2000;20(12):4265-74.
-
1999: Cockerill G W; Saklatvala J; Ridley S H; Yarwood H; Miller N E; Oral B; Nithyanathan S; Taylor G; Haskard D O
High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(4):910-7.
-
1999: Dean J L; Brook M; Clark A R; Saklatvala J
p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes.
The Journal of biological chemistry 1999;274(1):264-9.
-
1999: Saklatvala J; Dean J; Finch A
Protein kinase cascades in intracellular signalling by interleukin-I and tumour necrosis factor.
Biochemical Society symposium 1999;64():63-77.
-
1998: Ridley S H; Dean J L; Sarsfield S J; Brook M; Clark A R; Saklatvala J
A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA.
FEBS letters 1998;439(1-2):75-80.
-
1998: Stylianou E; Saklatvala J
Interleukin-1.
The international journal of biochemistry & cell biology 1998;30(10):1075-9.
-
1998: Krause A; Holtmann H; Eickemeier S; Winzen R; Szamel M; Resch K; Saklatvala J; Kracht M
Stress-activated protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB.
The Journal of biological chemistry 1998;273(37):23681-9.
-
1997: Finch A; Holland P; Cooper J; Saklatvala J; Kracht M
Selective activation of JNK/SAPK by interleukin-1 in rabbit liver is mediated by MKK7.
FEBS letters 1997;418(1-2):144-8.
-
1997: Guesdon F; Waller R J; Saklatvala J
Specific detection of an interleukin 1- and tumour necrosis factor-activated beta-casein kinase in HeLa and KB cells.
Cytokine 1997;9(7):471-9.
-
1997: Crawley J B; Rawlinson L; Lali F V; Page T H; Saklatvala J; Foxwell B M
T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation.
The Journal of biological chemistry 1997;272(23):15023-7.
-
1996: Saklatvala J; Rawlinson L; Waller R J; Sarsfield S; Lee J C; Morton L F; Barnes M J; Farndale R W
Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue.
The Journal of biological chemistry 1996;271(12):6586-9.
-
1996: Saklatvala J; Davis W; Guesdon F
Interleukin 1 (IL1) and tumour necrosis factor (TNF) signal transduction.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1996;351(1336):151-7.
-
1995: Guesdon F; Ikebe T; Stylianou E; Warwick-Davies J; Haskill S; Saklatvala J
Interleukin 1-induced phosphorylation of MAD3, the major inhibitor of nuclear factor kappa B of HeLa cells. Interference in signalling by the proteinase inhibitors 3,4-dichloroisocoumarin and tosylphenylalanyl chloromethylketone.
The Biochemical journal 1995;307 ( Pt 1)():287-95.
-
1995: Saklatvala J
Intracellular signalling mechanisms of interleukin 1 and tumour necrosis factor: possible targets for therapy.
British medical bulletin 1995;51(2):402-18.
-
1994: Kracht M; Truong O; Totty N F; Shiroo M; Saklatvala J
Interleukin 1 alpha activates two forms of p54 alpha mitogen-activated protein kinase in rabbit liver.
The Journal of experimental medicine 1994;180(6):2017-25.
-
1994: Guesdon F; Waller R J; Saklatvala J
Specific activation of beta-casein kinase by the inflammatory cytokines interleukin 1 and tumour necrosis factor.
The Biochemical journal 1994;304 ( Pt 3)():761-8.
-
1994: Kracht M; Shiroo M; Marshall C J; Hsuan J J; Saklatvala J
Interleukin-1 activates a novel protein kinase that phosphorylates the epidermal-growth-factor receptor peptide T669.
The Biochemical journal 1994;302 ( Pt 3)():897-905.
-
1994: Freshney N W; Rawlinson L; Guesdon F; Jones E; Cowley S; Hsuan J; Saklatvala J
Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27.
Cell 1994;78(6):1039-49.
-
1994: Thompson H L; Marshall C J; Saklatvala J
Characterization of two different forms of mitogen-activated protein kinase kinase induced in polymorphonuclear leukocytes following stimulation by N-formylmethionyl-leucyl-phenylalanine or granulocyte-macrophage colony-stimulating factor.
The Journal of biological chemistry 1994;269(13):9486-92.
-
1993: Saklatvala J; Rawlinson L M; Marshall C J; Kracht M
Interleukin 1 and tumour necrosis factor activate the mitogen-activated protein (MAP) kinase kinase in cultured cells.
FEBS letters 1993;334(2):189-92.
-
1993: Thompson H L; Shiroo M; Saklatvala J
The chemotactic factor N-formylmethionyl-leucyl-phenylalanine activates microtubule-associated protein 2 (MAP) kinase and a MAP kinase kinase in polymorphonuclear leucocytes.
The Biochemical journal 1993;290 ( Pt 2)():483-8.
-
1993: Guesdon F; Freshney N; Waller R J; Rawlinson L; Saklatvala J
Interleukin 1 and tumor necrosis factor stimulate two novel protein kinases that phosphorylate the heat shock protein hsp27 and beta-casein.
The Journal of biological chemistry 1993;268(6):4236-43.
-
1992: Stylianou E; O'Neill L A; Rawlinson L; Edbrooke M R; Woo P; Saklatvala J
Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes.
The Journal of biological chemistry 1992;267(22):15836-41.
-
1992: Saklatvala J; Guesdon F
Interleukin 1 and tumor necrosis factor signal transduction mechanisms: potential targets for pharmacological control of inflammation.
The Journal of rheumatology. Supplement 1992;32():65-9; discussion 69-70.
-
1992: O'Neill L A; Ikebe T; Sarsfield S J; Saklatvala J
The binding subunit of pertussis toxin inhibits IL-1 induction of IL-2 and prostaglandin production.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(2):474-9.
-
1991: Guesdon F; Saklatvala J
Identification of a cytoplasmic protein kinase regulated by IL-1 that phosphorylates the small heat shock protein, hsp27.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(10):3402-7.
-
1991: Saklatvala J; Kaur P; Guesdon F
Phosphorylation of the small heat-shock protein is regulated by interleukin 1, tumour necrosis factor, growth factors, bradykinin and ATP.
The Biochemical journal 1991;277 ( Pt 3)():635-42.
-
1991: Richards C D; Rafferty J A; Reynolds J J; Saklatvala J
Porcine collagenase from synovial fibroblasts: cDNA sequence and modulation of expression of RNA in vitro by various cytokines.
Matrix (Stuttgart, Germany) 1991;11(3):161-7.
-
1991: Saklatvala J; Guesdon F
Interleukin 1 signal transduction.
Agents and actions. Supplements 1991;35():35-40.
-
1990: O'Neill L A; Bird T A; Saklatvala J
How does interleukin 1 activate cells? Interleukin 1 signal transduction.
Immunology today 1990;11(11):392-4.
-
1990: Bird T A; Davies A; Baldwin S A; Saklatvala J
Interleukin 1 stimulates hexose transport in fibroblasts by increasing the expression of glucose transporters.
The Journal of biological chemistry 1990;265(23):13578-83.
-
1990: O'Neill L A; Bird T A; Gearing A J; Saklatvala J
Interleukin-1 signal transduction. Increased GTP binding and hydrolysis in membranes of a murine thymoma line (EL4).
The Journal of biological chemistry 1990;265(6):3146-52.
-
1990: Bird T A; Saklatvala J
Down-modulation of epidermal growth factor receptor affinity in fibroblasts treated with interleukin 1 or tumor necrosis factor is associated with phosphorylation at a site other than threonine 654.
The Journal of biological chemistry 1990;265(1):235-40.
-
1990: Saklatvala J; Bird T A; Kaur P; O'Neill L A
IL-1 signal transduction: evidence of activation of G protein and protein kinase.
Progress in clinical and biological research 1990;349():285-95.
-
1989: Kaur P; Welch W J; Saklatvala J
Interleukin 1 and tumour necrosis factor increase phosphorylation of the small heat shock protein. Effects in fibroblasts, Hep G2 and U937 cells.
FEBS letters 1989;258(2):269-73.
-
1989: Bird T A; Saklatvala J
IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(1):126-33.
-
1988: Bird T A; Gearing A J; Saklatvala J
Murine interleukin 1 receptor. Direct identification by ligand blotting and purification to homogeneity of an interleukin 1-binding glycoprotein.
The Journal of biological chemistry 1988;263(24):12063-9.
-
1988: Bird T A; Gearing A J; Saklatvala J
Studies on the murine interleukin-1 receptor.
Developments in biological standardization 1988;69():83-91.
-
1987: Bird T A; Gearing A J; Saklatvala J
Murine interleukin-1 receptor: differences in binding properties between fibroblastic and thymoma cells and evidence for a two-chain receptor model.
FEBS letters 1987;225(1-2):21-6.
-
1987: Bird T A; Saklatvala J
Studies on the fate of receptor-bound 125I-interleukin 1 beta in porcine synovial fibroblasts.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(1):92-7.
-
1986: Bird T A; Saklatvala J
Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells.
Nature 1986;324(6094):263-6.
-
1985: Saklatvala J; Sarsfield S J; Townsend Y
Pig interleukin 1. Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation, and fever.
The Journal of experimental medicine 1985;162(4):1208-22.
-
1984: Saklatvala J; Pilsworth L M; Sarsfield S J; Gavrilovic J; Heath J K
Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein.
The Biochemical journal 1984;224(2):461-6.
-
1983: Pilsworth L M; Saklatvala J
The cartilage-resorbing protein catabolin is made by synovial fibroblasts and its production is increased by phorbol myristate acetate.
The Biochemical journal 1983;216(2):481-9.
-
1983: Saklatvala J; Curry V A; Sarsfield S J
Purification to homogeneity of pig leucocyte catabolin, a protein that causes cartilage resorption in vitro.
The Biochemical journal 1983;215(2):385-92.
-
1983: Saklatvala J; Sarsfield S J; Pilsworth L M
Characterization of proteins from human synovium and mononuclear leucocytes that induce resorption of cartilage proteoglycan in vitro.
The Biochemical journal 1983;209(2):337-44.
-
1982: Saklatvala J; Sarsfield S J
Lymphocytes induce resorption of cartilage by producing catabolin.
The Biochemical journal 1982;202(1):275-8.
Sign-in to see more